These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35732100)

  • 1. Potential linear B-cells epitope change to a helix structure in the spike of Omicron 21L or BA.2 predicts increased SARS-CoV-2 antibodies evasion.
    Al-Zyoud W; Haddad H
    Virology; 2022 Aug; 573():84-95. PubMed ID: 35732100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein.
    Javanmardi K; Segall-Shapiro TH; Chou CW; Boutz DR; Olsen RJ; Xie X; Xia H; Shi PY; Johnson CD; Annapareddy A; Weaver S; Musser JM; Ellington AD; Finkelstein IJ; Gollihar JD
    Cell Host Microbe; 2022 Sep; 30(9):1242-1254.e6. PubMed ID: 35988543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals.
    Emmelot ME; Vos M; Boer MC; Rots NY; de Wit J; van Els CACM; Kaaijk P
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
    Cao Y; Yisimayi A; Jian F; Song W; Xiao T; Wang L; Du S; Wang J; Li Q; Chen X; Yu Y; Wang P; Zhang Z; Liu P; An R; Hao X; Wang Y; Wang J; Feng R; Sun H; Zhao L; Zhang W; Zhao D; Zheng J; Yu L; Li C; Zhang N; Wang R; Niu X; Yang S; Song X; Chai Y; Hu Y; Shi Y; Zheng L; Li Z; Gu Q; Shao F; Huang W; Jin R; Shen Z; Wang Y; Wang X; Xiao J; Xie XS
    Nature; 2022 Aug; 608(7923):593-602. PubMed ID: 35714668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals.
    Emmelot ME; Vos M; Boer MC; Rots NY; van Els CACM; Kaaijk P
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant.
    Arora P; Zhang L; Rocha C; Graichen L; Nehlmeier I; Kempf A; Cossmann A; Ramos GM; Baier E; Tampe B; Moerer O; Dickel S; Winkler MS; Behrens GMN; Pöhlmann S; Hoffmann M
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies.
    Focosi D; McConnell S; Casadevall A
    Drug Resist Updat; 2022 Dec; 65():100882. PubMed ID: 36260961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First cases of infection with the 21L/BA.2 Omicron variant in Marseille, France.
    Colson P; Delerce J; Beye M; Levasseur A; Boschi C; Houhamdi L; Tissot-Dupont H; Yahi N; Million M; La Scola B; Fantini J; Raoult D; Fournier PE
    J Med Virol; 2022 Jul; 94(7):3421-3430. PubMed ID: 35243660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3.
    Huang M; Wu L; Zheng A; Xie Y; He Q; Rong X; Han P; Du P; Han P; Zhang Z; Zhao R; Jia Y; Li L; Bai B; Hu Z; Hu S; Niu S; Hu Y; Liu H; Liu B; Cui K; Li W; Zhao X; Liu K; Qi J; Wang Q; Gao GF
    Immunity; 2022 Aug; 55(8):1501-1514.e3. PubMed ID: 35777362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.
    Willett BJ; Grove J; MacLean OA; Wilkie C; De Lorenzo G; Furnon W; Cantoni D; Scott S; Logan N; Ashraf S; Manali M; Szemiel A; Cowton V; Vink E; Harvey WT; Davis C; Asamaphan P; Smollett K; Tong L; Orton R; Hughes J; Holland P; Silva V; Pascall DJ; Puxty K; da Silva Filipe A; Yebra G; Shaaban S; Holden MTG; Pinto RM; Gunson R; Templeton K; Murcia PR; Patel AH; Klenerman P; Dunachie S; ; ; Haughney J; Robertson DL; Palmarini M; Ray S; Thomson EC
    Nat Microbiol; 2022 Aug; 7(8):1161-1179. PubMed ID: 35798890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
    Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
    mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion.
    Hossain A; Akter S; Rashid AA; Khair S; Alam ASMRU
    Microb Pathog; 2022 Sep; 170():105699. PubMed ID: 35944840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
    J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Genome Analysis Reveals the Evolution and Potential Impact of SARS-CoV-2 Omicron Structural Changes on Host Immune Evasion and Antiviral Therapeutics.
    Chauhan D; Chakravarty N; Jeyachandran AV; Jayakarunakaran A; Sinha S; Mishra R; Arumugaswami V; Ramaiah A
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bias of Asparagine to Lysine mutations in SARS-CoV-2 outside the receptor binding domain affects protein flexibility.
    Boer JC; Pan Q; Holien JK; Nguyen TB; Ascher DB; Plebanski M
    Front Immunol; 2022; 13():954435. PubMed ID: 36569921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of CD8
    Swaminathan S; Lineburg KE; Panikkar A; Raju J; Murdolo LD; Szeto C; Crooks P; Le Texier L; Rehan S; Dewar-Oldis MJ; Barnard PJ; Ambalathingal GR; Neller MA; Short KR; Gras S; Khanna R; Smith C
    Nat Commun; 2022 Oct; 13(1):6387. PubMed ID: 36302758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations.
    Trombetta CM; Piccini G; Pierleoni G; Leonardi M; Dapporto F; Marchi S; Andreano E; Paciello I; Benincasa L; Lovreglio P; Buonvino N; Decaro N; Stufano A; Lorusso E; Bombardieri E; Ruello A; Viviani S; Rappuoli R; Molesti E; Manenti A; Montomoli E
    Commun Biol; 2022 Sep; 5(1):903. PubMed ID: 36056181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants.
    Banerjee A; Lew J; Kroeker A; Baid K; Aftanas P; Nirmalarajah K; Maguire F; Kozak R; McDonald R; Lang A; Gerdts V; Straus SE; Gilbert L; Li AX; Mozafarihashjin M; Walmsley S; Gingras AC; Wrana JL; Mazzulli T; Colwill K; McGeer AJ; Mubareka S; Falzarano D
    Med; 2022 Jun; 3(6):422-432.e3. PubMed ID: 35437520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike protein.
    Wang A; Tian Y; Liu H; Ding P; Chen Y; Liang C; Du Y; Jiang D; Zhu X; Yin J; Zhang G
    Emerg Microbes Infect; 2022 Dec; 11(1):2120-2131. PubMed ID: 35916768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
    Khan K; Khan SA; Jalal K; Ul-Haq Z; Uddin R
    Virology; 2022 Jul; 572():28-43. PubMed ID: 35576833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.